Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Atherosclerosis|February 9, 2010
ABC transporters, atherosclerosis and inflammationMichael L Fitzgerald, Zahedi Mujawar, Norimasa Tamehiro
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2005
Distinct cellular loci for the ABCA1-dependent and ABCA1-independent lipid efflux mediated by endogenous apolipoprotein E expressionZhi H Huang, Michael L Fitzgerald, Theodore Mazzone
Journal of Molecular Medicine (Berlin, Germany)|May 22, 2002
Nuclear hormone receptors and cholesterol trafficking: the orphans find a new homeMichael L Fitzgerald, Kathryn J Moore, Mason W Freeman
Atherosclerosis|July 19, 2011
HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7Nobukiyo Tanaka, Sumiko Abe-Dohmae, Noriyuki Iwamoto, et al.
Journal of Lipid Research|May 25, 2010
Helical apolipoproteins of high-density lipoprotein enhance phagocytosis by stabilizing ATP-binding cassette transporter A7Nobukiyo Tanaka, Sumiko Abe-Dohmae, Noriyuki Iwamoto, et al.
The Journal of Biological Chemistry|October 18, 2002
Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levelsHiroaki Fukumoto, Amy Deng, Michael C Irizarry, et al.
Biochemistry|February 18, 2004
Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1Angeliki Chroni, Tong Liu, Michael L Fitzgerald, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2020
A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumorsTracy Murray Stewart, Apurva A Desai, Michael L Fitzgerald, et al.
Journal of Alzheimer'S Disease : JAD|August 24, 2011
Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activityWoojin S Kim, Andrew F Hill, Michael L Fitzgerald, et al.
Pageof 5